PAULLI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 5.235
EU - Europa 3.802
AS - Asia 2.432
Continente sconosciuto - Info sul continente non disponibili 9
AF - Africa 5
OC - Oceania 4
SA - Sud America 4
Totale 11.491
Nazione #
US - Stati Uniti d'America 5.194
CN - Cina 2.302
IE - Irlanda 1.367
UA - Ucraina 638
FI - Finlandia 501
DE - Germania 381
IT - Italia 294
SE - Svezia 256
GB - Regno Unito 157
FR - Francia 91
SG - Singapore 58
BE - Belgio 49
IN - India 45
CA - Canada 36
CZ - Repubblica Ceca 21
RU - Federazione Russa 21
JP - Giappone 10
NL - Olanda 10
EU - Europa 8
RO - Romania 5
AU - Australia 4
TR - Turchia 4
IR - Iran 3
PL - Polonia 3
SV - El Salvador 3
BR - Brasile 2
GR - Grecia 2
HK - Hong Kong 2
ID - Indonesia 2
MU - Mauritius 2
NG - Nigeria 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
BG - Bulgaria 1
BO - Bolivia 1
CH - Svizzera 1
CL - Cile 1
DK - Danimarca 1
ES - Italia 1
ET - Etiopia 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MS - Montserrat 1
MX - Messico 1
MY - Malesia 1
NP - Nepal 1
Totale 11.491
Città #
Dublin 1.366
Chandler 1.300
Jacksonville 770
Nanjing 613
Ashburn 302
Nanchang 278
Beijing 263
Princeton 237
Lawrence 225
Wilmington 207
Ann Arbor 205
Medford 201
Hebei 196
Helsinki 170
New York 164
Changsha 159
Shenyang 157
Jiaxing 148
Boardman 143
Shanghai 141
Tianjin 107
Hangzhou 82
Milan 68
Woodbridge 59
Norwalk 51
Brussels 49
Los Angeles 47
Verona 42
Seattle 40
Pavia 39
Pune 38
Singapore 31
Toronto 31
Falls Church 27
Fairfield 25
Houston 24
Des Moines 20
Dearborn 19
Brno 18
Jinan 18
Kunming 17
Zhengzhou 14
Chicago 13
Washington 13
Ningbo 11
Auburn Hills 10
Lanzhou 9
Tokyo 9
Guangzhou 8
Piscataway 8
Redwood City 8
Tappahannock 8
Taizhou 7
Rome 6
San Francisco 6
Xi'an 6
Florence 5
Genova 5
Moscow 5
Cinisello Balsamo 4
Falkenstein 4
Fuzhou 4
Naples 4
Zelo Buon Persico 4
Berlin 3
Borås 3
Haikou 3
London 3
Melbourne 3
Munich 3
Novokuznetsk 3
Nuremberg 3
Olomouc 3
Orange 3
Rockville 3
San Salvador 3
Santa Clara 3
Andover 2
Ballabio 2
Baltimore 2
Baoding 2
Borgomanero 2
Cambridge 2
Casatenovo 2
Cerignola 2
Changchun 2
City of Westminster 2
Cremona 2
Dallas 2
Ferrara 2
Gatchina 2
Genoa 2
Grumento Nova 2
Haarlem 2
Jakarta 2
Kaohsiung 2
Magenta 2
Manchester 2
Menlo Park 2
Monmouth Junction 2
Totale 8.353
Nome #
Anaplastic large cell lymphoma CD30/Ki-1 positive, expressing the CD15/Leu-M1 antigen. Immunohistochemical and morphological relationships to Hodgkin's disease. 90
Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT. 90
Systematic analysis of human oncogenic viruses in colon cancer revealed EBV latency in lymphoid infiltrates. 87
Splenic nodal and extranodal marginal zone lymphoma: features of bone marrow involvement. 85
Nijmegen breakage syndrome associated T-cell-rich B-cell lymphoma: case report 84
Human cytomegalovirus early infection, acute rejection, and major histocompatibility class II expression in transplanted lung. Molecular, immunocytochemical, and histopathologic investigations. 83
A complex immunodeficiency: Idiopathic CD4+T-lymphocytopenia and hypogammaglobulinemia associated with HHV8 infection. Kaposi's sarcoma and gastric cancer. 82
Abdominal lymphographic pattern in connective tissue diseases is quite similar to that observed in lymphocytic lymphoma. 82
Primary cutaneous large B-cell lymphoma of the leg: histogenetic analysis of a controversial clinicopathologic entity 81
Immunophenotypic characterization of the cell infiltrate in 5 cases of Sinus Histiocytosis with massive lymphoadenopathy. 80
Immunofluorescence and enzyme histochemistry on consecutive sections from glycol-methacrylate-embedded bone marrow, lymph node and kidney specimens. 80
Multiple granulocytic sarcoma during complete hematologic remission of acute nonlymphoid leukemia. 79
Antibiotic therapy-induced remission of bladder mucosa-associated lymphoid tissue (MALT) lymphoma carrying t(11;18)(q21;q21) apoptosis inhibitor 2-MALT1. 79
A low serum beta 2-microglobulin level despite bulky tumor is a characteristic feature of primary mediastinal (thymic) large B-cell lymphoma: implicatios for serologic staging. 77
Prostatic adenocarcinoma with oncocytic features. 76
[Castleman's disease: update] 76
Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia 75
Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL), leg-type and other: an update on morphology and treatment. 75
B-cell posttransplant lymphoproliferative disorders in heart and/or lungs recipients: clinical and molecular-histogenetic study of 17 cases from a single institution 74
Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma. 74
Uncommon syndromes and treatment manifestations of malignancy: case 1. Unusual association of lupus and sarcoma. 73
Cathepsin D and E co-expression in sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) and langerhans' cell histiocytosis: further evidences of a phenotypic overlap between these histiocytic disorders. 73
Aberrant somatic hypermutation in post-transplant lymphoproliferative disorders. 72
High resolution genome-wide array-comparative genomic hybridization in splenic marginal zone B-cell lymphoma 72
CD30/Ki-1-positive lymphoproliferative disorders of the skin--clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group. 72
Epstein-Barr virus infection and altered control of apoptotic pathways in posttransplant lymphoproliferative disorders. 71
Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma. 70
Analysis of immunoglobulin heavy and light chain variable genes in post-transplant lymphoproliferative disorders 69
Bilateral inguinal hernia with dislocation of great saphenous vein as complication of long-standing granulomatous slack skin: a case report 69
An insidious presentation of splenic marginal zone lymphoma 69
Mediastinal B-cell lymphoma: a study of its histomorphologic spectrum based on 109 cases 68
Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma. 68
Assessment of bone marrow involvement in non-Hodgkin's lymphomas: comparison between histology and flow cytometry. 68
Prognostic evaluations tailored to specific gastric neuroendocrine neoplasms: Analysis of 200 cases with extended follow-up 68
Absence of MYD88 L265P mutation in blastic plasmacytoid dendritic cell neoplasm 68
Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B. 67
The clinical value of tumor burden at diagnosis in Hodgkin lymphoma 67
CD5(-) diffuse large B-cell lymphoma with peculiar cyclin D1+ phenotype. Pathologic and molecular characterization of a single case 67
Evidence for a polyclonal nature of the cell infiltrate in sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). 67
Bone Marrow-Derived Mesenchymal Stromal Cells Locally Injected Induce An Up-Regulation Of Both Circulating And Mucosal Foxp3+ Regulatory T-Cells In Patients With Perianal Crohn’s Disease 67
Lymph node reticulum cell neoplasm with progression into cytokeration-positive interstitial reticulum cell (CIRC) sarcoma: a case study 66
Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT 66
ALK+ lymphoma: clinico-pathological findings and outcome. 65
Reactive hemophagocytosis in Ki-1 positive largeb cell lymphoma: a case study. 65
Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma. 65
Bayesian models identify specific lymphoproliferative disorders associated with hepatitis C virus infection 65
Sinus histiocytosis with massive lymphoadenopathy (Rosai-Dorfman disease). Clinico-pathological analysis of a paediatric case 64
ALK positive lymphohistiocytic variant of anaplastic large cell lymphoma in an adult. 64
Lymphangioma of the spleen in an elderly patient. 64
Amyloid typing: immunoelectron microscopy 64
Induction Of Immune Tolerance To Gluten In Coeliac Disease After Allogeneic Haematopoietic Stem Cell Transplantation For Thalassaemia Major 64
Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. 64
Distinctive clinical and histological features of Waldenström's macroglobulinemia and splenic marginal zone lymphoma. 64
EBV positive primary cutaneous CD30+ large T-cell lymphoma in a heart transplanted patient: case report. 63
MYD88 (L265P) mutation is an independent risk factor for progression in patients with IgM monoclonal gammopathy of undetermined significance 63
Linfoma a grandi cellule anaplastiche 61
Regression of indolent B-cell lymphoma after Lamivudine prophylaxis of hepatitis B virus infection. 61
Primary cutaneous B-cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: Comparison with current classification and definition of prognostic markers 61
Bone Marrow-Derived Mesenchymal Stromal Cell Intra-Fistular Injections Induce An Up-Regulation Of Foxp3+ Regulatory T-Cells In Patients With Crohn’s Disease 61
Kaposi's Sarcoma in a child after autologous bone marrow transplantation for non-Hodgkin's lymphoma 60
Cutaneous CD30+ lymphoproliferative disorders: expression of bcl-2 and proteins of the tumor necrosis factor receptor superfamily 60
Reversal of nephrotic syndrome due to reactive amyloidosis (AA-type) after excision of localized Castleman's disease. 60
Dedifferentiating endometrial adenocarcinoma. Report of a case. 60
Nijmegen breakage syndrome-associated T-cell-rich B-cell lymphoma: Case report 60
Molecular lesions of signalling pathway genes in clonal B-cell lymphocytosis with marginal zone features. 60
Cytotoxic/natural killer cell cuteneous lymphomas: report of EORTC Cutaneous Lymphoma Task Force Workshop 59
Constant activation of the RAF-MEK-ERK pathway as a diagnostic and therapeutic target in hairy cell leukemia 59
Cytophagic histiocytic panniculitis and subcutaneous panniculitis-like T-cell lymphoma: report of 7 cases. 58
In situ lymphocyte subpopulation in alopecia areata after treatment with squaric acid dibutyl ester G. 58
Epstein-Barr Virus positive aggressive lymphoma as a consequence of immunosuppression after multiple salvage treatments for follicular lymphoma. 58
Adult ki-1-positive large cell anaplastic lymphoma presenting with skin lesions. 58
Cathepsin E in antigen-presenting Langerhans and interdigitating reticulum cells. Its possible role in antigen processing. 58
Intestinal T-cell lymphoma with enteropathy-associated T-cell lymphoma-like features arising in the setting of adult autoimmune enteropathy 58
Splenic marginal zone lymphoma: hydra with many heads? 57
Bone marrow histology in marginal zone B-cell lymphomas: correlation with clinical parameters and flow cytometry in 120 patients 57
Histopathology of nodal and extranodal non-hodgkin's lymphomas 56
Natural killer and T-cell cytotoxic cuteneous lymphomas. 56
Incidence of novel N-glycosylation sites in the B-cell receptor of lymphomas associated with immunodeficiency. 56
Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomas. 56
Splenic marginal zone cell lymphoma: report of an indolent variant without massive splenomegaly presumably representing an early phase of the disease. 56
Successful treatment of a classic Hodgkin lymphoma-type post-transplant lymphoproliferative disorder with tailored chemotherapy and Epstein-Barr virus-specific cytotoxic T lymphocytes in a pediatric heart transplant recipient. 56
Small Bowel Carcinomas in Coeliac or Crohn's Disease: Clinico-pathological, Molecular and Prognostic Features. A Study from the Small Bowel Cancer Italian Consortium 56
Diode Laser-assisted surgical therapy for early treatment of oral mucocele in a newborn patient: case report and procedures checklist. 56
Depletion of circulating IgM memory B cells predicts unfavourable outcome in COVID-19 56
Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection. 56
Kaposis's sarcoma 55
[Primary CD30+ large-cell non-Hodgkin's lymphoma of the soft tissues. Clinico-pathologic study of a case]. 55
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation 55
Comparative genome-wide profiling of post-transplant lymphoproliferative disorders and diffuse large B-cell lymphomas 54
Nodular lymphocyte predominance Hodgkin's disease: long-term observation reveals a continuous pattern of recurrence. 54
The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms 54
[The Haemolymphopathology Italian Group (H.I.G.): an essential resource for the new technical and organization problems troubling modern haemolymphopathology diagnostics] 53
Detection of Active Epstein-Barr Virus Infection in Duodenal Mucosa of Patients With Refractory Celiac Disease 53
Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma 53
Small bowel carcinomas in celiac or Crohn's disease: distinctive histophenotypic, molecular and histogenetic patterns 53
Acute kidney injury caused by COVID-19 in a patient with Crohn's disease treated with adalimumab 53
Prognostic factors in primary cutaneous B-cell lymphoma : The italian study group for cutaneous lymphomas 52
[Primary non-Hodgkin's lymphoma of the breast. Clinico-pathologic study of 2 cases] 52
Gene expression of pyrogenic cytokines in Hodgkin's disease lymph nodes. 52
Primary gastric CD30 (Ki-1)positive large cell Non Hodgkin Lymphomas. A clinicopathologic analysis six cases. 52
Totale 6.504
Categoria #
all - tutte 45.013
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.013


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.640 742 1.013 4 122 5 133 51 149 7 256 143 15
2020/20211.271 150 109 39 121 14 169 26 193 75 178 158 39
2021/20221.020 17 13 36 18 36 40 18 81 57 18 141 545
2022/20233.763 372 301 37 321 363 378 1 211 1.598 18 104 59
2023/20241.488 178 263 40 102 90 418 56 92 11 61 67 110
2024/202596 96 0 0 0 0 0 0 0 0 0 0 0
Totale 11.777